Medifast, Inc. (LON:0K05)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	101.69	90.93	94.44	87.69	104.18	163.72
Short-Term Investments	60.98	71.42	55.6	-	5.36	10.75
Cash & Short-Term Investments	162.67	162.34	150.04	87.69	109.54	174.48
Cash Growth	-0.51%	8.20%	71.10%	-19.95%	-37.21%	88.26%
Inventory	30.2	42.42	54.59	118.86	180.04	53.39
Prepaid Expenses	9.05	9.64	10.67	16.24	16.33	6.45
Other Current Assets	4.51	-	8.73	-	0.95	-
Total Current Assets	206.44	214.4	224.03	222.78	306.87	234.31
Property, Plant & Equipment	43.45	48.68	67.11	75.65	80.59	38.14
Long-Term Deferred Tax Assets	11.46	11.46	4.12	5.33	4.4	0.69
Other Long-Term Assets	7.98	9.67	14.65	12.46	6.47	2.94
Total Assets	269.33	284.21	309.91	316.21	398.33	276.08
Accounts Payable	40.26	23.05	39.19	53.12	70.89	36.09
Accrued Expenses	-	23.3	36.48	49.03	67.18	50.15
Current Portion of Leases	5.92	6.18	5.89	5.78	6.52	3.67
Current Income Taxes Payable	-	1.49	-	0.43	-	-
Current Unearned Revenue	-	0.32	0.57	7.36	8.05	7.61
Other Current Liabilities	-	9.82	10.17	25.19	17.19	13.83
Total Current Liabilities	46.18	64.16	92.3	140.89	169.83	111.35
Long-Term Leases	7.14	9.94	16.13	20.28	26.02	7.49
Total Liabilities	53.33	74.1	108.43	161.17	195.85	118.84
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	37.32	33.14	26.57	21.56	12.02	7.84
Retained Earnings	178.49	176.78	174.65	139.85	190.33	154.35
Treasury Stock	-	-	-	-6.4	-	-5
Comprehensive Income & Other	0.18	0.18	0.25	0.02	0.11	0.04
Shareholders' Equity	216.01	210.11	201.48	155.04	202.47	157.25
Total Liabilities & Equity	269.33	284.21	309.91	316.21	398.33	276.08
Total Debt	13.07	16.13	22.01	26.05	32.54	11.16
Net Cash (Debt)	149.61	146.22	128.03	61.64	77	163.31
Net Cash Growth	3.60%	14.21%	107.70%	-19.95%	-52.85%	106.53%
Net Cash Per Share	13.60	13.34	11.72	5.47	6.52	13.78
Filing Date Shares Outstanding	10.27	10.66	10.78	10.78	11.5	11.72
Total Common Shares Outstanding	10.27	10.66	10.78	10.81	11.55	11.72
Working Capital	160.26	150.24	131.73	81.89	137.03	122.96
Book Value Per Share	21.03	19.71	18.69	14.34	17.53	13.41
Tangible Book Value	216.01	210.11	201.48	155.04	202.47	157.25
Tangible Book Value Per Share	21.03	19.71	18.69	14.34	17.53	13.41
Land	-	0.35	0.57	0.57	0.57	0.57
Buildings	-	21.35	24.5	25.91	23.52	13.01
Machinery	-	44.97	50.44	49.38	42.85	21.1

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.